253 related articles for article (PubMed ID: 17242426)
1. A pilot study of the effects of atomoxetine on driving performance in adults with ADHD.
Barkley RA; Anderson DL; Kruesi M
J Atten Disord; 2007 Feb; 10(3):306-16. PubMed ID: 17242426
[TBL] [Abstract][Full Text] [Related]
2. Effects of two doses of alcohol on simulator driving performance in adults with attention-deficit/hyperactivity disorder.
Barkley RA; Murphy KR; O'Connell T; Anderson D; Connor DF
Neuropsychology; 2006 Jan; 20(1):77-87. PubMed ID: 16460224
[TBL] [Abstract][Full Text] [Related]
3. Effects of two doses of methylphenidate on simulator driving performance in adults with attention deficit hyperactivity disorder.
Barkley RA; Murphy KR; O'Connell T; Connor DF
J Safety Res; 2005; 36(2):121-31. PubMed ID: 15896352
[TBL] [Abstract][Full Text] [Related]
4. Hyperactive children as young adults: driving abilities, safe driving behavior, and adverse driving outcomes.
Fischer M; Barkley RA; Smallish L; Fletcher K
Accid Anal Prev; 2007 Jan; 39(1):94-105. PubMed ID: 16919226
[TBL] [Abstract][Full Text] [Related]
5. Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders.
Wilens TE; Adler LA; Weiss MD; Michelson D; Ramsey JL; Moore RJ; Renard D; Brady KT; Trzepacz PT; Schuh LM; Ahrbecker LM; Levine LR;
Drug Alcohol Depend; 2008 Jul; 96(1-2):145-54. PubMed ID: 18403134
[TBL] [Abstract][Full Text] [Related]
6. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
[TBL] [Abstract][Full Text] [Related]
7. Driving impairments in teens and adults with attention-deficit/hyperactivity disorder.
Barkley RA
Psychiatr Clin North Am; 2004 Jun; 27(2):233-60. PubMed ID: 15063996
[TBL] [Abstract][Full Text] [Related]
8. Atomoxetine in the management of children with ADHD: effects on quality of life and school functioning.
Brown RT; Perwien A; Faries DE; Kratochvil CJ; Vaughan BS
Clin Pediatr (Phila); 2006 Nov; 45(9):819-27. PubMed ID: 17041169
[TBL] [Abstract][Full Text] [Related]
9. Simulated driving changes in young adults with ADHD receiving mixed amphetamine salts extended release and atomoxetine.
Kay GG; Michaels MA; Pakull B
J Atten Disord; 2009 Jan; 12(4):316-29. PubMed ID: 18815438
[TBL] [Abstract][Full Text] [Related]
10. Quality of life assessment in adult patients with attention-deficit/hyperactivity disorder treated with atomoxetine.
Adler LA; Sutton VK; Moore RJ; Dietrich AP; Reimherr FW; Sangal RB; Saylor KE; Secnik K; Kelsey DK; Allen AJ
J Clin Psychopharmacol; 2006 Dec; 26(6):648-52. PubMed ID: 17110824
[TBL] [Abstract][Full Text] [Related]
11. [Atomoxetine for the treatment of attention-deficit/hyperactivity disorder].
Davids E; Gastpar M
Fortschr Neurol Psychiatr; 2004 Oct; 72(10):586-91. PubMed ID: 15472782
[TBL] [Abstract][Full Text] [Related]
12. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.
Schulz KP; Fan J; Bédard AC; Clerkin SM; Ivanov I; Tang CY; Halperin JM; Newcorn JH
Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622
[TBL] [Abstract][Full Text] [Related]
13. Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.
Dell'Agnello G; Maschietto D; Bravaccio C; Calamoneri F; Masi G; Curatolo P; Besana D; Mancini F; Rossi A; Poole L; Escobar R; Zuddas A;
Eur Neuropsychopharmacol; 2009 Nov; 19(11):822-34. PubMed ID: 19716683
[TBL] [Abstract][Full Text] [Related]
14. Comparison of parent and teacher reports of attention-deficit/hyperactivity disorder symptoms from two placebo-controlled studies of atomoxetine in children.
Biederman J; Gao H; Rogers AK; Spencer TJ
Biol Psychiatry; 2006 Nov; 60(10):1106-10. PubMed ID: 16806096
[TBL] [Abstract][Full Text] [Related]
15. Atomoxetine treatment of attention-deficit/hyperactivity disorder.
Eiland LS; Guest AL
Ann Pharmacother; 2004 Jan; 38(1):86-90. PubMed ID: 14742801
[TBL] [Abstract][Full Text] [Related]
16. Manual transmission enhances attention and driving performance of ADHD adolescent males: pilot study.
Cox DJ; Punja M; Powers K; Merkel RL; Burket R; Moore M; Thorndike F; Kovatchev B
J Atten Disord; 2006 Nov; 10(2):212-6. PubMed ID: 17085632
[TBL] [Abstract][Full Text] [Related]
17. Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder.
Bangs ME; Hazell P; Danckaerts M; Hoare P; Coghill DR; Wehmeier PM; Williams DW; Moore RJ; Levine L;
Pediatrics; 2008 Feb; 121(2):e314-20. PubMed ID: 18245404
[TBL] [Abstract][Full Text] [Related]
18. Effects of atomoxetine on self-reported high-risk behaviors and health-related quality of life in adolescents with ADHD.
Saylor K; Williams DW; Schuh KJ; Wietecha L; Greenbaum M
Curr Med Res Opin; 2010 Sep; 26(9):2087-95. PubMed ID: 20642391
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of self-evaluation in adults with ADHD: evidence from a driving study.
Knouse LE; Bagwell CL; Barkley RA; Murphy KR
J Atten Disord; 2005 May; 8(4):221-34. PubMed ID: 16110052
[TBL] [Abstract][Full Text] [Related]
20. An open-label, dose-titration tolerability study of atomoxetine hydrochloride in Japanese adults with attention-deficit/hyperactivity disorder.
Takahashi M; Takita Y; Goto T; Ichikawa H; Saito K; Matsumoto H; Tanaka Y
Psychiatry Clin Neurosci; 2011 Feb; 65(1):55-63. PubMed ID: 21265936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
